Wendy J. Sherman, M.D.

  1. Neurologist

Publications

  1. Suarez-Meade P, Marenco-Hillembrand L, Sherman WJ. Neuro-oncologic Emergencies. Curr Oncol Rep. 2022 Aug; 24 (8):975-984 Epub 2022 Mar 30
    View PubMed
  2. Ramos-Fresnedo A, Domingo RA, Perez-Vega C, Pullen MW, Akinduro OO, Almeida JP, Jentoft ME, Bendok BR, Chaichana KL, Trifiletti DM, Burns TC, Porter AB, Kizilbash SH, Middlebrooks EH, Quinones-Hinojosa A, Sherman WJ. The early infiltrative phase of GBM hypothesis: are molecular glioblastomas histological glioblastomas in the making? A preliminary multicenter study. J Neurooncol. 2022 Jul; 158 (3):497-506 Epub 2022 June 14
    View PubMed
  3. Rivera Perla KM, Tang OY, Durfey SNM, Vivas-Buitrago T, Sherman WJ, Parney I, Uhm JH, Porter AB, Elinzano H, Toms SA, Quinones-Hinojosa A. Predicting access to postoperative treatment after glioblastoma resection: an analysis of neighborhood-level disadvantage using the Area Deprivation Index (ADI). J Neurooncol. 2022 Jul; 158 (3):349-357 Epub 2022 May 03
    View PubMed
  4. Ramos-Fresnedo A, Pullen MW, Perez-Vega C, Domingo RA, Akinduro OO, Almeida JP, Suarez-Meade P, Marenco-Hillembrand L, Jentoft ME, Bendok BR, Trifiletti DM, Chaichana KL, Porter AB, Quinones-Hinojosa A, Burns TC, Kizilbash SH, Middlebrooks EH, Sherman WJ. The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study. J Neurooncol. 2022 Mar; 157 (1):177-185 Epub 2022 Feb 17
    View PubMed
  5. Vivas-Buitrago T, Domingo RA, Tripathi S, De Biase G, Brown D, Akinduro OO, Ramos-Fresnedo A, Sabsevitz DS, Bendok BR, Sherman W, Parney IF, Jentoft ME, Middlebrooks EH, Meyer FB, Chaichana KL, Quinones-Hinojosa A. Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma. J Neurosurg. 2022 Jan 1; 136 (1):1-8 Epub 2021 June 04
    View PubMed
  6. Ramos-Fresnedo A, Domingo RA, Sanchez-Garavito JE, Perez-Vega C, Akinduro OO, Jentoft ME, Vora SA, Brown PD, Porter AB, Bendok BR, Link MJ, Middlebrooks EH, Trifiletti DM, Chaichana KL, Quiñones-Hinojosa A, Sherman WJ. The impact of multiple lesions on progression-free survival of meningiomas: a 10-year multicenter experience. J Neurosurg. 2021 Nov 19; 1-9. [Epub ahead of print]
    View PubMed
  7. Tripathi S, Vivas-Buitrago T, Domingo RA, Biase G, Brown D, Akinduro OO, Ramos-Fresnedo A, Sherman W, Gupta V, Middlebrooks EH, Sabsevitz DS, Porter AB, Uhm JH, Bendok BR, Parney I, Meyer FB, Chaichana KL, Swanson KR, Quinones-Hinojosa A. IDH-wild-type glioblastoma cell density and infiltration distribution influence on supramarginal resection and its impact on overall survival: a mathematical model. J Neurosurg. 2021 Oct 29; 1-9 [Epub ahead of print]
    View PubMed
  8. Marenco-Hillembrand L, Erben Y, Suarez-Meade P, Franco-Mesa C, Sherman W, Eidelman BH, Miller DA, O'Keefe NL, Bendok BR, Spinner RJ, Chaichana KL, Meschia JF, Quinones-Hinojosa A. Outcomes and Surgical Considerations for Neurosurgical Patients Hospitalized with COVID-19-A Multicenter Case Series. World Neurosurg. 2021 Oct; 154:e118-e129 Epub 2021 July 06
    View PubMed
  9. Akinduro OO, Garcia DP, Higgins DMO, Vivas-Buitrago T, Jentoft M, Solomon DA, Daniels DJ, Pennington Z, Sherman WJ, Delgardo M, Bydon M, Kalani MA, Zanazzi G, Tsankova N, Bendok BR, McCormick PC, Sciubba DM, Lo SL, Clarke JL, Abode-Iyamah K, Quinones-Hinojosa A. A multicenter analysis of the prognostic value of histone H3 K27M mutation in adult high-grade spinal glioma. J Neurosurg Spine. 2021 Aug 20; 35 (6):834-843
    View PubMed
  10. Sherman WJ, Vitaz TW. Nivolumab with radiation therapy in a glioblastoma patient with Lynch syndrome. BMJ Case Rep. 2021 Apr 27; 14 (4)
    View PubMed
  11. Khan M, Baird GL, Price T, Tubergen T, Kaskar O, De Jesus M, Zachariah J, Oostema A, Scurek R, Coleman RR, Sherman W, Hingtgen C, Abdelhak T, Smith B, Silver B. Stroke code simulation benefits advanced practice providers similar to neurology residents. Neurol Clin Pract. 2018 Apr; 8 (2):116-119
    View PubMed
  12. Novak J, Sherman W, Vitaz T. Schwannoma response to interferon alpha INAT. 2017; 10:1-3.
  13. Sherman WJ, Raizer JJ. Medical management of meningiomas. CNS Oncol. 2013 Mar; 2 (2):161-70
    View PubMed
  14. Sherman WJ, Raizer JJ. Chemotherapy: What is its role in meningioma? Expert Rev Neurother. 2012 Oct; 12 (10):1189-95; quiz 1196
    View PubMed
  15. Goldberg RP, Sherman W, Sand PK. Cystoscopy for lower urinary tract symptoms in urogynecologic practice: the likelihood of finding bladder cancer. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jul; 19 (7):991-4 Epub 2008 Feb 01
    View PubMed
  16. Goldberg RP, Abramov Y, Botros S, Miller JJ, Gandhi S, Nickolov A, Sherman W, Sand PK. Delivery mode is a major environmental determinant of stress urinary incontinence: results of the Evanston-Northwestern Twin Sisters Study. Am J Obstet Gynecol. 2005 Dec; 193 (6):2149-53
    View PubMed
  17. Abramov Y, Gandhi S, Botros SM, Goldberg RP, Sherman W, Rurak M, Sand PK. Do alterations in vaginal dimensions after reconstructive pelvic surgeries affect the risk for dyspareunia? Am J Obstet Gynecol. 2005 May; 192 (5):1573-7
    View PubMed
PST-20492184